FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

386866004: Carteolol (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2003. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
1461044010 Carteolol (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
1480980010 Carteolol en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
57971000195119 carteololo it Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
798061000172110 cartéolol fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module
73131000195113 Carteolol de Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Carteolol (substance) Is a Non-selective beta-blocking agent false Inferred relationship Some
Carteolol (substance) Is a Propanolamine (substance) true Inferred relationship Some
Carteolol (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Beta adrenergic receptor antagonist (disposition) true Inferred relationship Some
Carteolol (substance) Is a Substance with beta adrenergic receptor antagonist mechanism of action (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing carteolol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carteolol (substance) Inferred relationship Some 1
Carteolol adverse reaction Causative agent (attribute) True Carteolol (substance) Inferred relationship Some 1
Allergy to carteolol (finding) Causative agent (attribute) False Carteolol (substance) Inferred relationship Some
Carteolol hydrochloride (substance) Is a False Carteolol (substance) Inferred relationship Some
Carteolol-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carteolol (substance) Inferred relationship Some 1
Allergy to carteolol (finding) Causative agent (attribute) True Carteolol (substance) Inferred relationship Some 1
Carteolol hydrochloride (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Carteolol (substance) Inferred relationship Some
Carteolol-containing product in ocular dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carteolol (substance) Inferred relationship Some 1
Product containing only carteolol (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carteolol (substance) Inferred relationship Some 1
Carteolol only product in ocular dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carteolol (substance) Inferred relationship Some 1
Carteolol only product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Carteolol (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start